GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Tax Rate %

MDXXF (Pharmala Biotech Holdings) Tax Rate % : 0.00% (As of Nov. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Pharmala Biotech Holdings's Tax Expense for the three months ended in Nov. 2024 was $0.00 Mil. Pharmala Biotech Holdings's Pre-Tax Income for the three months ended in Nov. 2024 was $-0.34 Mil. Therefore, Pharmala Biotech Holdings's Tax Rate % for the quarter that ended in Nov. 2024 was 0.00%.

Pharmala Biotech Holdings Tax Rate % Historical Data

The historical data trend for Pharmala Biotech Holdings's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Tax Rate % Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Tax Rate %
- - - -

Pharmala Biotech Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24 Nov24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmala Biotech Holdings Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Pharmala Biotech Holdings's Tax Rate % for the fiscal year that ended in Aug. 2024 is calculated as

Tax Rate %=Tax Expense (A: Aug. 2024 )/Pre-Tax Income (A: Aug. 2024 )
=0/-0.603
=0.00 %

Pharmala Biotech Holdings's Tax Rate % for the quarter that ended in Nov. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Nov. 2024 )/Pre-Tax Income (Q: Nov. 2024 )
=0/-0.343
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings Tax Rate % Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Tax Rate %
Comparable Companies
XCNQ:PHRM XCNQ:TELI TSX:BCT TSXV:SBM XCNQ:PREV XCNQ:DOSE TSXV:HEM TSXV:KNE TSXV:RKV XCNQ:BIOV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
MDMA:Canada
Address
1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9
Website
https://www.pharmala.ca
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.